SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea · Delayed Price · Currency is KRW 844.00
-11.00 (-1.29%)
At close: Mar 13, 2026
SCM Lifescience Market Cap
SCM Lifescience has a market cap or net worth of 37.31 billion as of March 13, 2026. Its market cap has increased by 38.30% in one year.
Market Cap
37.31B
Enterprise Value
28.41B
Revenue
1.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
844.00
Market Cap Chart
Since June 17, 2020, SCM Lifescience's market cap has decreased from 398.06B to 37.31B, a decrease of -90.63%. That is a compound annual growth rate of -33.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 37.31B | -16.60% |
| Dec 30, 2025 | 44.73B | 15.58% |
| Dec 30, 2024 | 38.70B | -49.97% |
| Dec 28, 2023 | 77.37B | -55.83% |
| Dec 29, 2022 | 175.14B | -25.10% |
| Dec 30, 2021 | 233.83B | -60.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 63.16B |
| SunBio,Inc. | 60.78B |
| Aptamer Sciences | 55.68B |
| NGeneBio | 53.67B |
| J2KBIO | 45.26B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| ADBiotech | 34.38B |